Sectors
MIRA
MIRA Pharmaceuticals, Inc.
0.79
1 x 0.69
1 x 0.88
bid
ask
+
0.02
2.97%
09:33 AM
timesize
| Ytd | -47.68% | |
| 1y | -42.75% |
0.79
day range
0.80
0.60
52 week range
2.45
| Open | 0.80 | Prev Close | 0.77 | Low | 0.79 | High | 0.80 | Mkt Cap | 33.20M |
| Vol | 3.49K | Avg Vol | 105.70K | EPS | -1.45 | P/E | -0.54 | Forward P/E | -2.14 |
| Beta | 1.54 | Short Ratio | 0.47 | Inst. Own | 5.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.91 | 200-d Avg | 1.18 | 1yr Est | 12.08 |
| Income Statement | |||
| Operating Expenses | 1.10M | ||
| Research and Development Expense | 524.78K | ||
| Selling, General and Administrative Expense | 578.70K | ||
| Operating Income | -1.10M | ||
| Net Income | -1.15M | ||
| Net Income Common Stock | -1.15M | ||
| Net Income Common Stock (USD) | -1.15M | ||
| Consolidated Income | -1.15M | ||
| Earnings per Basic Share | -0.03 | ||
| Earnings per Basic Share (USD) | -0.03 | ||
| Earnings per Diluted Share | -0.03 | ||
| Earning Before Interest & Taxes (EBIT) | -1.15M | ||
| Earning Before Interest & Taxes (USD) | -1.15M | ||
| Weighted Average Shares | 41.94M | ||
| Weighted Average Shares Diluted | 41.94M | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.82M | ||
| Cash and Equivalents (USD) | 4.82M | ||
| Investments | 4.59M | ||
| Investments Current | 4.59M | ||
| Trade and Non-Trade Receivables | 35.44K | ||
| Current Assets | 9.43M | ||
| Total Assets | 9.46M | ||
| Current Liabilities | 114.76K | ||
| Total Liabilities | 114.76K | ||
| Accumulated Retained Earnings (Deficit) | -40.73M | ||
| Shareholders Equity | 9.35M | ||
| Shareholders Equity (USD) | 9.35M | ||
| Assets Non-Current | 35.44K | ||
| Trade and Non-Trade Payables | 34.01K | ||
| Cash Flow | |||
| Net Cash Flow from Financing | -330.61K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.53M | ||
| Issuance (Repayment) of Debt Securities | -330.61K | ||
| Net Cash Flow from Operations | -1.20M | ||
| Share Based Compensation | 107.59K | ||